The p.Val142Ile variant in transthyretin (encoded by the TTR gene) is the most common genetic cause of transthyretin-related amyloidosis. This allele is particularly prevalent in communities ofAfrican descent compared with populations of different ancestries, where its frequency is two orders of magnitude lower. For this reason, p.Val142Ile has always been considered an “African” variant, with limited studies performed on individuals of European descent. However, recent reports of higher-than-expected prevalence in European-ancestry populations question the African specificity of this allele. Here we show that the high recurrence of p.Val142Ile in central Italy is due to a founder effect and not to recent admixture from African populations, highlighting how this may be the case in other communities. This suggests a probable underestimate of the global prevalence of p.Val142Ile, and further emphasizes the importance of routine inclusion of TTR in gene panels used for clinical genetic testing in hypertrophic cardiomyopathy (independently of the patient’s geographical origin), that transthyretin-related amyloidosis can mimic.
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy / Mazzarotto F.; Argiro Alessia; Zampieri M.; Magri C.; Giotti I.; Boschi B.; Frusconi S.; Gennarelli M.; Buxbaum J.; Polimanti R.; Olivotto Iacopo.; Perfetto F.; Cappelli F.. - In: EUROPEAN JOURNAL OF HUMAN GENETICS. - ISSN 1018-4813. - STAMPA. - (2022), pp. 1-7. [10.1038/s41431-022-01235-2]
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy
Mazzarotto F.;Argiro Alessia;Zampieri M.;Giotti I.;Olivotto Iacopo.;Perfetto F.;Cappelli F.
2022
Abstract
The p.Val142Ile variant in transthyretin (encoded by the TTR gene) is the most common genetic cause of transthyretin-related amyloidosis. This allele is particularly prevalent in communities ofAfrican descent compared with populations of different ancestries, where its frequency is two orders of magnitude lower. For this reason, p.Val142Ile has always been considered an “African” variant, with limited studies performed on individuals of European descent. However, recent reports of higher-than-expected prevalence in European-ancestry populations question the African specificity of this allele. Here we show that the high recurrence of p.Val142Ile in central Italy is due to a founder effect and not to recent admixture from African populations, highlighting how this may be the case in other communities. This suggests a probable underestimate of the global prevalence of p.Val142Ile, and further emphasizes the importance of routine inclusion of TTR in gene panels used for clinical genetic testing in hypertrophic cardiomyopathy (independently of the patient’s geographical origin), that transthyretin-related amyloidosis can mimic.File | Dimensione | Formato | |
---|---|---|---|
val122 high recurrence mazzarotto cappelli.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
1.79 MB
Formato
Adobe PDF
|
1.79 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.